Recent

% | $
Quotes you view appear here for quick access.

LeMaitre Vascular, Inc. Message Board

  • biotuesday biotuesday Oct 10, 2013 12:17 PM Flag

    BioTuesdays: Roth starts LeMaitre Vascular at buy

    October 10, 2013 by Jennifer Poland · Leave a Comment

    Roth Capital Partners has initiated coverage LeMaitre Vascular (NASDAQ:LMAT) with a “buy” rating and 12-month price target of $10. The stock closed at $6.73 on Wednesday.

    see BioTuesdays for rest of brief...

 
LMAT
14.41+0.06(+0.42%)Jul 22 4:00 PMEDT